WilliamTempleMD

UCSF Pediatric Hematology & Oncology

Dr. Temple is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
550 16th St
4th Floor, 4551, Box 0110
San Francisco, CA 94143
Phone+1 415-476-6245

Fax+1 415-476-5354

UCSF Pediatric Hematologist-Oncologist with expertise in Pediatric Blood & Marrow Transplantation and Cellular Therapy.
Assistant Professor of Pediatrics, Division of Allergy, Immunology, Bone Marrow Transplantation and Division of Oncology.

University of California, San FranciscoPediatric Bone Marrow Transplantation and Immunotherapy, 2022 - 2024
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2019 - 2022
University of California (San Francisco)Residency, Pediatrics, 2016 - 2019
University of California San Francisco School of MedicineClass of 2016

PubMed

5 citations
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies.
William C Temple, Matthew A Nix, Akul Naik, Adila Izgutdina, Benjamin J Huang
Journal for Immunotherapy of Cancer. 2023-11-24
3 citations
Structural surfaceomics reveals an AML-specific conformation of integrin βas a CAR T cellular therapy target.
Kamal Mandal, Gianina Wicaksono, Clinton Yu, Jarrett J Adams, Michael R Hoopmann
Nature Cancer. 2023-11-01
9 citations
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.
William C Temple, Stephanie Mueller, Michelle L Hermiston, Birgit Burkhardt
Best Practice & Research. Clinical Haematology. 2023-03-01

Journal Articles

Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies
William C Temple, Matthew A Nix, Akul Naik, Adila Izgutdina, Benjamin J Huang, Gianina Wicaksono, Paul Phojanakong, Juan Antonio Camara Serrano, Elizabeth P Young, Emi..., Journal for ImmunoTherapy of Cancer, 11/25/2023
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients
Savannah S Shumock, William C Temple, Amanda Marinoff, Kathryn Aaronson, Erica Southworth, Simayijiang Xirenayi, Alex G Lee, Stanley G Leung, E Alejandro Sweet-Cordero..., Cancer Rep (Hoboken)